InvestorsHub Logo
Followers 75
Posts 4648
Boards Moderated 0
Alias Born 09/06/2003

Re: dewophile post# 6895

Friday, 04/05/2024 4:34:35 PM

Friday, April 05, 2024 4:34:35 PM

Post# of 7239

Why can’t they raise prices as therapeutics comes online to levels that are still acceptable to payers (especially if duration Pam’s out saving md visits etc)



Ie the Allergan strategy. However I’d suggest this is monitored by CMS etc and is thus a whole lot harder to do after the fact. They will notice ‘predatory’ price increases (eg therapeutics increasing by 20% a year - the 10% that’s normal for many different therapeutic drugs plus an additional 10% to catch up) in a way they wouldn’t have noticed had it started like Allergan. And then they’d notice the fiction that allows such decoupling (the ‘coupons’ etc on the aesthetics side).

That said, yes, I’m being extreme. I suspect they will manage to decouple aesthetics and therapeutics pricing to some degree. Over time. But it will be slow to avoid catching attention.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RVNC News